p-Aminobenzoic acid derivatives as acetylcholinesterase inhibitors

Eur J Med Chem. 2005 Jul;40(7):732-5. doi: 10.1016/j.ejmech.2005.03.011. Epub 2005 Apr 25.

Abstract

Because Alzheimer's disease (AD) is a medical problem characterized by progressive loss of memory and cognition that is associated with a deficient cholinergic system, this work aims to evaluate some p-aminobenzoic acid (PABA) derivatives as acetylcholinesterase inhibitors in vitro, in continuation with our last studies. The assayed compounds are low toxic, simple-structured and low cost.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 4-Aminobenzoic Acid / chemical synthesis*
  • 4-Aminobenzoic Acid / pharmacology
  • Acetylcholinesterase / drug effects
  • Alzheimer Disease / drug therapy
  • Animals
  • Binding Sites
  • Cattle
  • Cholinesterase Inhibitors / chemical synthesis*
  • Cholinesterase Inhibitors / pharmacology
  • Models, Molecular

Substances

  • Cholinesterase Inhibitors
  • Acetylcholinesterase
  • 4-Aminobenzoic Acid